VRTX seems pretty well occupied with executing on the programs it already has and doesn’t strike me as being in a predator mode.
Do you think that VRTX will ultimately need to make a move for an NS5A inhibitor and/or PI, though, as I and I suspect jq believe, to compete effectively down the road in the HCV space?